New York (March 29th, 2013) - Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) traded at $ 40.34 in the last session, which is +2.11 (5.52%). The stock has a Range of 38.66 - 41.25. The stock has a 52 week low and high of 11.75 - 41.25 respectively. The stock has a Market Cap of 1.03B. The stock traded a volume of 1.16M. The stock has a 30 day average volume of 534,277.00.
Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry. In 2012, FDA drug approvals totaled a 15-year high of 39, over the past decade drug approvals has averaged roughly 23 a year, according to a recent Bloomberg article.
Find out what could be next for AEGR here:
Chicago Bridge & Iron Company N.V. (NYSE: CBI) hosted an Investor Day in New York today. During the meeting, CB&I's management team demonstrated the company's confidence in its end markets as well as its ability to capture new business and help clients meet the growing demand for energy infrastructure.
In his opening remarks, CB&I President and Chief Executive Officer Philip K. Asherman stated, "We are excited to have this opportunity to introduce our company’s newest management team members. Their strong leadership and proven technical skills will greatly contribute to our continued focus of meeting and exceeding our clients’ expectations and creating value for our shareholders. You will hear from the collective talent of our four operating groups that provide us the structure to scale our business model, which is unique in our industry by combining like businesses while capitalizing on each group’s unique resource capability and commercial characteristics."
Find out more on CBI here:
Stockreportdaily.com issues momentum alerts on stocks that can provide gains to day traders. Stockreportdaily.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. Stockreportdaily.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Stockreportdaily.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Stockreportdaily.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership. Simply sign up for free and start receiving exclusive alerts. Subscribe Here: http://www.Stockreportdaily.comDisclosure: Stockreportdaily.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Stockreportdaily.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks. For full disclaimer visit; http://www.Stockreportdaily.com/disclaimer/
Contact Info:George FitzStock Report Dailyinfo@Stockreportdaily.com347-905-5009